期刊文献+

临床试验中救助治疗对临床效应评价的影响研究 被引量:1

Research on the Impact of Rescue Therapy to the Evaluation of Clinical Effects in Clinical Trials
下载PDF
导出
摘要 目的本文引入秩方法对含有救助治疗的临床试验疗效结果进行分析,并与目前国内常用方法进行比较,为分析该类数据选择合适的方法提供统计学依据。方法采用Monte Carlo模拟的方法,考虑调整患者不同时点观测值之间的相关系数和救助阈值,分析疗效评价的Ⅰ型错误和检验效能,并与目前国内常用的完整案例分析和末次观测结转法进行比较。结果Ⅰ型错误方面,当救助比例在20%左右时,不同方法差异较小,当救助比例较大时,按时间和末次观测值调整的秩方法是最佳的方法。效能方面,当救助比例小于40%时,所有方法效能均大于0.8,当救助比例较大时,按末次观测值调整的秩方法是最佳的方法。结论在实际研究过程中,需要根据实际情况选择合适的分析方法,而不是直接采用完整案例分析和末次观测结转法,以得到更有效的结果。救助治疗的分析方法可以为安慰剂对照试验提供一种新的设计和分析思路。 Objective Author introduces and improves rank method to analyze the results of clinical trials containing rescue therapy, compares it with the conventional methods and provides statistical basis for the analysis of such data to select the appropriate method. Methods Through Monte Carlo simulation, consider adjusting the correlation coefficient of the observed values of the same patient at different points and rescue threshold,compare type Ⅰ error and power of efficacy evaluation among rank method and conventional methods (complete case analysis (CC) and last observation carried forward (LOCF)). Results In terms of type Ⅰ error, when the rescue proportion is about 20%, the difference between different methods is small;when the rescue proportion is large,rank method adjusted with time and last visit (ARTLV) is the best choice. In terms of power, when the rescue proportion is less than 40%, the power of all methods is larger than 0.8, when the rescue proportion is large, rank method adjusted with last visit (ARLV) is the best choice. Conclusion Researchers should select appropriate method based on actual situation to get accurate results. It's ethical to set rescue therapy in placebo-controlled trials, so analysis method of rescue therapy can provide a new idea for the design and analysis of placebo-controlled trials.
出处 《中国卫生统计》 CSCD 北大核心 2015年第3期370-374,共5页 Chinese Journal of Health Statistics
基金 自身免疫性疾病和病毒性肝炎等重大疾病的国际化新药临床评价研究技术平台建设(2012ZX09303019001)
关键词 救助治疗 秩方法 Ⅰ型错误 检验效能 Rescue therapy Rank method Type Ⅰ error Power
  • 相关文献

参考文献13

  • 1Ian RW, Christina B, Pollyanna H, et al. Randomized clinical trials with added rescue medication:some approaches to their analysis and interpretation. Statistics in Medicine ,2001,20(20) :2995-3008.
  • 2唐健元,杨志敏,杨进波,黄钦,吴春芳,冯毅.临床研究中缺失值的类型和处理方法研究[J].中国卫生统计,2011,28(3):338-341. 被引量:27
  • 3陈渊成,张菁.确证性临床试验中数据缺失的处理指南[J].中国新药杂志,2012,21(7):732-736. 被引量:10
  • 4European Medicines Agency. Guideline on missing data in confirma- tory clinical trials. Committee for Medical Product for Human Use: London, 2010.
  • 5庞新生.缺失数据处理方法的比较[J].统计与决策,2010,26(24):152-155. 被引量:27
  • 6Ohidul S, HM James Hung, Robert O'Neill. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. Journal of Biopharmaceutical Statistics, 2009,19 ( 2 ) : 227- 246.
  • 7Ohidul S. MMRM versus MI in dealing with missing data-a compari- son based on 25 NDA data sets. Journal of Biopharmaceutical Statis- tics ,2011,21 (3) :423-436.
  • 8Donald BR. Multiple imputation for non-response in surveys, vol. 307. New York: Wiley ,2009 : 15-17.
  • 9John ML. Worst-rank score analysis with informatively missing ob- servations in clinical trials. Control Clin Trials, 1999,20 (5):408- 422.
  • 10Andrea B, Douglas GA, Patrick R, et al. The design of simulation studies in medical statistics. Statistics in Medicine, 2006,25 ( 24 ) : 4279-4292.

二级参考文献36

共引文献65

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部